Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ARDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ARDX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Ardelyx Inc

ARDX
Current price
3.63 USD +0.12 USD (+3.42%)
Last closed 3.56 USD
ISIN US0396971071
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 863 710 528 USD
Yield for 12 month -41.92 %
1Y
3Y
5Y
10Y
15Y
ARDX
21.11.2021 - 28.11.2021

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. Address: 400 Fifth Avenue, Waltham, MA, United States, 02451

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.73 USD

P/E ratio

Dividend Yield

Financials ARDX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ARDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+333 615 000 USD

Last Year

+124 456 000 USD

Current Quarter

+74 114 000 USD

Last Quarter

+116 129 000 USD

Current Year

+283 059 000 USD

Last Year

+106 661 000 USD

Current Quarter

+64 151 000 USD

Last Quarter

+97 865 000 USD
EBITDA -37 391 000 USD
Operating Margin TTM -49.05 %
Price to Earnings
Return On Assets TTM -6.58 %
PEG Ratio -0.080
Return On Equity TTM -36.26 %
Wall Street Target Price 10.73 USD
Revenue TTM 361 705 984 USD
Book Value 0.61 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 61.00 %
Dividend Yield
Gross Profit TTM 249 299 008 USD
Earnings per share -0.23 USD
Diluted Eps TTM -0.23 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -14.86 %

Stock Valuation ARDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.23
Price Sales TTM 2.39
Enterprise Value EBITDA -27.36
Price Book MRQ 5.93

Technical indicators ARDX

For 52 weeks

3.21 USD 8.06 USD
50 Day MA 4.13 USD
Shares Short Prior Month 27 769 893
200 Day MA 5.16 USD
Short Ratio 4.59
Shares Short 29 048 525
Short Percent 13.76 %